Trending

#ECOR

Latest posts tagged with #ECOR on Bluesky

Latest Top
Trending

Posts tagged #ECOR

Preview
Bioelectronic firm electroCore to share 2025 results in Mar. 19 webinar Investors get electroCore’s Q4 and 2025 update after market close on Mar. 19, with a 4:30 PM EDT webinar and Q&A session available by dial-in or Zoom.

#ECOR electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026

www.stocktitan.net/news/ECOR/electro-core-t...

0 0 0 0

It's out!!

youtu.be/UDtshfQrhYs

#ECoR

8 2 2 2

Current queue for Esin the Magazines Guy:

#4: Venturing into the Antalya Organized Industrial Zone to pick up some issues of NTV Tarih
#5: Looking through Ot Special Issue 2025/02 (it almost became lost media)
#6: The anti-AI shift in Bilim ve Teknik

Which one are you the most excited for?

#ECoR

0 0 0 0
The not-well-known 2025 restructuring of #tarih | Esin the Magazines Guy #3
The not-well-known 2025 restructuring of #tarih | Esin the Magazines Guy #3 YouTube video by Esin's Corner of Randomness

Speaking of Esin the Magazines Guy... Its 3rd episode was released around three weeks ago! It's about the 2025 restructuring (issues #121-124) of the #tarih magazine!

#ECoR #YouTube #Magazines #Video

www.youtube.com/watch?v=CtXY...

0 0 0 0
Preview
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million electroCore (Nasdaq: ECOR) reported preliminary unaudited full-year 2025 results and guidance: record revenue expected at $31.8–$32.0 million, representing ~26% growth versus 2024 ($25.2M). Fourth-quarter 2025 revenue is anticipated at $9.0–$9.2 million, about 30% growth versus Q4 2024. The company ended 2025 with approximately $11.6 million in cash, cash equivalents, and marketable securities, down from ~$13.2 million at September 30, 2025. electroCore described these figures as preliminary unaudited guidance and plans a full operational and financial update on its Q4 and FY2025 earnings call in March 2026.

#ECOR electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

www.stocktitan.net/news/ECOR/electro-core-p...

0 0 0 0
Post image

Quoted Micro 19 January 2026 - #SWC #AJAX #VULT #EDGE #WCAP #LFT #ZNT #SNOX #ECP #ETHY #HODL #EOP #BWAP #TRX #DPP #CMCL #SHOE #IQE #SOS #ARV #CNS #DFCH #TERN #MIRI #EQT #MPAC #CCT #WNX #AAZ #PPHC #MKA #CLBX #SKA #DVNO #HSW #NANO #PALM #ECOR

www.branduk.net/quoted-micro...

0 0 0 0
Video

🔥 #TWINPETESINVESTING #Podcast 170:🥳A New Year Special with four guests discussing potential winning stocks for 2026. #CNC #RELX #EMG #STB $EOSE #CURY $WBD #BRWM #ECOR #APN #RIO #Netflix #Paramount #Mergers #Takeover #Investing #Dividends

youtu.be/jwQNSpsgDmE?...

open.spotify.com/episode/3rOA...

4 0 31 1

#ECOR TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

www.stocktitan.net/news/ECOR/tac-stim-demon...

0 0 0 0
Preview
electroCore Announces Third Quarter 2025 Financial Results Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024 Cash, cash equivalents, restricted cash, and marketable securities (“Total Cash”) of $13.2 million as of September 30, 2025 Company to host a conference call and webcast

#ECOR electroCore Announces Third Quarter 2025 Financial Results

www.stocktitan.net/news/ECOR/electro-core-a...

0 0 0 0
October's magazines, #tarih under Kafa, and Bilim ve Teknik May 1998 | Esin the Magazines Guy #2
October's magazines, #tarih under Kafa, and Bilim ve Teknik May 1998 | Esin the Magazines Guy #2 YouTube video by Esin's Corner of Randomness

Happy Republic Day!! Esin the Magazines Guy #2 is now out! I check out the October 2025 issues of Kafkaokur and Bilim ve Teknik, issue #5 of Çok, issues #94 and #29 of #tarih, and I also talk about the May 1998 issue (#366) of Bilim ve Teknik!

#ECoR #YouTube #Magazines #Video

youtu.be/BznzM271B6Q

2 4 0 0
Preview
34% Recovery Rate: electroCore's Non-Invasive Brain Treatment Shows Promise for 2.5M Annual TBI Patients Study of 102 patients shows gammaCore nerve stimulation improved 16 of 22 post-concussion symptoms. Treatment effective for both recent injuries and year-old cases. No adverse events reported.

#ECOR gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms

www.stocktitan.net/news/ECOR/gamma-core-non...

0 0 0 0
Preview
Major Reimbursement Win: electroCore's gammaCore Headache Device Gets National Coverage in Belgium electroCore's gammaCore Sapphire receives RIZIV/INAMI reimbursement coverage in Belgium for cluster headache treatment, effective Oct 1, 2025. Partnership with Silvert Medical enables European expansion.

#ECOR electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium

www.stocktitan.net/news/ECOR/electro-core-a...

0 0 0 0
Checking out September's magazines! | Esin the Magazines Guy #1
Checking out September's magazines! | Esin the Magazines Guy #1 YouTube video by Esin's Corner of Randomness

Esin the Magazines Guy #1 is out! In this video I check out the issues of Kafasına Göre, Bilim ve Teknik, Kafkaokur, and Ot that were released in September 2025 (this month)!

#ECoR #YouTube #Magazines #Video

youtu.be/woWCH7q5ctg

1 2 0 0
Preview
Digital Health Veteran Who Led First FDA-Cleared BP Watch Takes Helm at electroCore's Wellness Division Former IBM Watson Health VP joins electroCore to transform consumer wellness strategy. Led development of groundbreaking FDA-cleared blood pressure watch. See growth plans.

#ECOR electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

www.stocktitan.net/news/ECOR/electro-core-n...

0 0 0 0
Preview
electroCore Announces Second Quarter 2025 Financial Results electroCore (NASDAQ: ECOR) reported strong Q2 2025 financial results with record revenue of $7.4 million, representing a 20% year-over-year increase. The company's year-to-date revenue reached $14.1 million, up 22% compared to the first half of 2024.Key financial metrics include gross profit of $6.4 million with an 87% margin, though operating expenses increased to $9.9 million. The company reported a GAAP net loss of $3.7 million ($0.44 per share). Cash position stood at $7.4 million as of June 30, 2025, supplemented by a recent $7.2 million term debt facility.electroCore projects full-year 2025 revenue of approximately $30.0 million with expected net cash usage between $3.9-$4.4 million for the remainder of the year. The company successfully completed the NeuroMetrix acquisition ahead of schedule.

#ECOR electroCore Announces Second Quarter 2025 Financial Results

www.stocktitan.net/news/ECOR/electro-core-a...

0 0 0 0

Merci : #MSHA @rnmsh.bsky.social #MISHA ‪@mshalpes.bsky.social‬‬ #Euroregion_NAEN @upvehu.bsky.social @upna.bsky.social #ECOr #LACES @univbordeaux.bsky.social @labexittem.bsky.social @ubmontaigne.bsky.social #euskampus @mshbordeaux.bsky.social

0 0 1 0

Gracias: #MSHA @rnmsh.bsky.social #MISHA ‪@mshalpes.bsky.social‬‬ #Euroregion_NAEN @upvehu.bsky.social u.bsky.social
@upna.bsky.social #ECOr #LACES @univbordeaux.bsky.social @labexittem.bsky.social @ubmontaigne.bsky.social #euskampus @mshbordeaux.bsky.social eaux.bsky.social

0 0 1 0

Thanks: #MSHA @rnmsh.bsky.social #MISHA ‪@mshalpes.bsky.social‬‬ #Euroregion_NAEN @upvehu.bsky.social @upna.bsky.social #ECOr #LACES @univbordeaux.bsky.social @labexittem.bsky.social @ubmontaigne.bsky.social #euskampus @mshbordeaux.bsky.social

0 0 1 0
Post image Post image Post image

#ViNU #VitaInu ViNU is on binance alpha ! sooo next is BINANCE LISTING !!! and then probably OKX too !

#crypto #cryptocoin #binance #okx #listing #memcoin #revolut #cryptocurrency #btc #ltc #doge #shib #shiba #floki #coin #market #binancealpha #alpha #BNB #eth #soph #pepe #ecor #gateio

0 0 0 0

Just In: ( NASDAQ: #ECOR ) Trading (ECOR) With Integrated Risk Controls

0 0 0 0

Theofilos & MAZ plan ElectroCore board changes

On May 14, 2025, Charles S. Theofilos and MAZ Partners disclosed plans to assess board or management changes, director nominations, board declassification, and governance improvements at ElectroCore, Inc #ECOR

0 0 1 0

Just In: ( NASDAQ: #ECOR ) PRISM Mid-Day Movers: Earnings Reactions for MedDevices and NextGen Tech & AI Indices Diverge

0 0 0 0
Preview
electroCore Announces First Quarter 2025 Financial Results electroCore (NASDAQ: ECOR) reported strong Q1 2025 financial results with net sales of $6.7 million, representing a 23% increase from Q1 2024. The company's core revenue excluding TAC-STIM grew by 29% year-over-year to $6.6 million. Key growth drivers included higher sales of prescription gammaCore™ in the VA market, international market expansion, and strong performance of Truvaga™ wellness products.The company maintained a robust gross margin of 85%. However, operating expenses increased to $9.5 million, resulting in a GAAP net loss of $3.9 million ($0.47 per share). The quarter included $665,000 in seasonal and non-recurring expenses related to Form 10-K filing, severance, and the NeuroMetrix acquisition.electroCore provided full-year 2025 guidance of approximately $30.0 million in total revenue and projects net cash usage of $3.8-4.3 million for the next three quarters. The company closed the quarter with $8.0 million in cash and equivalents.

#ECOR electroCore Announces First Quarter 2025 Financial Results

www.stocktitan.net/news/ECOR/electro-core-a...

0 0 0 0
Preview
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio Strategic acquisition brings Quell Fibromyalgia platform to electroCore's bioelectronic portfolio. See how this merger transforms chronic pain treatment delivery. Learn more.

#ECOR electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

www.stocktitan.net/news/ECOR/electro-core-c...

0 0 0 0
Preview
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial New clinical data reveals gammaCore's effectiveness for both recent and chronic brain injuries. Treatment improved headaches, nausea, and depression. See full results.

#ECOR gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

www.stocktitan.net/news/ECOR/gamma-core-non...

0 0 0 0
Preview
electroCore Smashes Revenue Records: 57% Growth and 85% Margins Signal Breakthrough Year electroCore delivers record-breaking 2024 with 57% revenue surge to $25.2M, slashes cash burn by 53%, and achieves 85% margins. Strong growth in VA/DOD and Truvaga segments.

#ECOR electroCore Announces Full Year 2024 Financial Results

www.stocktitan.net/news/ECOR/electro-core-a...

0 0 0 0
Preview
Bioelectronic Medicine Pioneer electroCore Sets Q4 Earnings Date - Key Details Inside electroCore will present Q4 and FY2024 results on March 12 after market close, followed by management discussion and Q&A at 5:30 PM EDT.

#ECOR electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

www.stocktitan.net/news/ECOR/electro-core-t...

0 0 0 0
Preview
Can This New Partnership Help Veterans Combat Opioid Withdrawal? electroCore Expands Treatment Options electroCore expands into opioid withdrawal treatment market by distributing Spark Biomedical's Sparrow Ascent device across VA facilities, leveraging existing network.

#ECOR electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

www.stocktitan.net/news/ECOR/electro-core-i...

0 0 0 0
Preview
This FDA-Cleared Device Claims to Reduce Stress and Improve Sleep - Now Available on Amazon Advanced vagus nerve stimulator promises natural stress relief, better sleep, and enhanced focus. Now available through Amazon's trusted platform.

#ECOR electroCore’s Truvaga™ Now Available on Amazon®

www.stocktitan.net/news/ECOR/electro-core-s...

0 0 0 0
Preview
Breakthrough Patents Bolster electroCore's Nerve Stimulation Tech: Smart Monitoring Meets Precision Treatment electroCore expands IP portfolio with USPTO patents covering advanced vagal nerve stimulation methods and smart monitoring systems, strengthening its position in neurostimulation technology.

#ECOR electroCore Expands Intellectual Property Portfolio

www.stocktitan.net/news/ECOR/electro-core-e...

0 0 0 0